Grant supports studies to improve and personalize bipolar care

A three-year, $4.5 million grant will support a three-pronged research project to map the brain circuits that contribute to mood shifts in bipolar disorder and help develop personalized therapies for the condition.

Food Hackathon students turn their ideas into delicious reality

Entrepreneurial Cornell students compete in the annual food hackathon, but then what? Their prototypes gain new ways to become reality.

First WCM-Q AI Hackathon drives health care tech innovation

Weill Cornell Medicine-Qatar hosted its first AI Hackathon – a collaborative, interdisciplinary event that brought together medical and computer science students to develop AI-driven solutions for pressing clinical challenges.

Neural implant smaller than salt grain wirelessly tracks brain

Cornell researchers and collaborators have developed a neural implant so small that it can rest on a grain of salt, yet it can wirelessly transmit brain activity data in a living animal for more than a year.

Startup bets their superfast microbe can rewrite biotech 

Researchers develop a new bacterium that can absorb DNA directly from its surroundings and incorporate it into its own genetic code.

Jacobs Center dedication honors alumna’s commitment to health

Since its founding in 2023, the Jacobs Center has been home to major advances in precision nutrition and health impacting all of Cornell’s campuses.

Sprayable RNA pesticide works best when potato beetles are small

The first sprayable insecticide made of RNA can target and kill ravenous Colorado potato beetles while sparing most beneficial insects, making it a promising environmentally friendly option.

Cornell startup aims to monitor heart and lung health without touch

Tracking heart and lung health without wires or electrodes could be a game-changer for home care, assisted living or for patients who resist traditional wearables.

Prescription drug lawsuit ads can pose public health risks

Drug-injury ads are a way for law firms to obtain clients, but when people who need these drugs see the ads, they sometimes stop taking their medication, which can have serious negative consequences, a Cornell researcher found.